Immunologic treatment strategies are established in malignant
melanoma treatment, mainly focusing on Interleukin-2 in advanced disease
and interferon alpha in the adjuvant situation. In advanced
disease, therapies with IL-2, interferon and different
chemotherapeutic agents were not associated with better patient
survival in the vast majority of patients. Therefore, an overview
of novel immunological agents and combined therapeutic approaches
is presented in this review, covering allogenic and autologous
vaccine strategies, dendritic cell vaccination, strategies for
adoptive immunotherapy and T cell receptor gene transfer,
treatment with cytokines and monoclonal antibodies against the
CTLA-4 antigen. As emerging treatment strategies are based on
individual molecular and immunological charac...MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
Read more...


